Funder
National Natural Science Foundation of China
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference72 articles.
1. Platinum(IV) anticancer agents; are we enroute to the holy grail or to a dead end?;Gibson;J. Inorg. Biochem.,2021
2. Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives;Lazarevic;Eur. J. Med. Chem.,2017
3. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: synthesis, characterization, cellular uptake and in vitro cytotoxicity;Chen;Eur. J. Med. Chem.,2020
4. Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs;Bergamo;Dalton Trans.,2011
5. KP1019, A new redox-active anticancer agent - preclinical development and results of a clinical phase I study in tumor patients;Christian;Chem. Biodivers.,2010
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献